Lin, LIzhu |
NCT05229809: Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer |
|
|
| Recruiting | 4 | 212 | RoW | Yiqi Wenyang Jiedu prescription, Simulation agent of Yiqi Wenyang Jiedu prescription | Jie Li | Gastric Carcinoma | 07/23 | 07/24 | | |
ETER701, NCT04234607: A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer |
|
|
| Not yet recruiting | 3 | 738 | RoW | TQB2450, Anlotinib, Etoposide, Carboplatin, TQB2450(blank), Anlotinib(blank) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Extensive Small Cell Lung Cancer | 12/22 | 12/22 | | |
NCT05042375: A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer |
|
|
| Recruiting | 3 | 450 | RoW | camrelizumab + famitinib, pembrolizumab, camrelizumab | Jiangsu HengRui Medicine Co., Ltd. | Non-small Cell Lung Cancer | 12/23 | 12/25 | | |
NCT05765825: Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC |
|
|
| Recruiting | 2 | 61 | RoW | serplulimab, HLX10, Cisplatin, Cisplatin injection, Carboplatin, Carboplatin injection, Etoposide, Etoposide injection, Thoracic radiation therapy (TRT), low-dose radiotherapy | Sichuan University | Extensive-stage Small-cell Lung Cancer | 06/24 | 12/25 | | |